Generation and characterization of transgenic mice expressing cobra venom factor

Molecular Immunology

Volumn 39, Issue 5-6, 2002, Pages 357-365

  Andrä, Jörg ^a   Halter, Roman ^b   Kock, Michael A ^a,e   Niemann, Heiner ^c   Vogel, Carl Wilhelm ^a,d   Paul, Dieter ^b,f  

^a UNIVERSITY OF HAMBURG   (Germany)

^b FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^c INSTITUT FÜR TIERZUCHT   (Germany)

^d UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^e BASF SE   (Germany)

^f Ingenium Pharmaceuticals AG   (Germany)

Author keywords

C3 depletion; Cobra venom factor; Complement; Complement inhibition

Indexed keywords

ALPHA 1 ANTITRYPSIN; COBROTOXIN; COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENTARY DNA; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; LIVER; MICROINJECTION; MOUSE; MOUSE STRAIN; NONHUMAN; OVARY CELL; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SERUM; STRAIN DIFFERENCE; TRANSGENIC MOUSE;

ANIMALS; COBRA VENOMS; COMPLEMENT C3; COMPLEMENT SYSTEM PROTEINS; HEMOLYSIS; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; MICE, TRANSGENIC; RNA, MESSENGER;

ANIMALIA; MURINAE; MUS MUSCULUS;

EID: 0036773249     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(02)00107-4     Document Type: Article

References (33)

1. Cochrane C.G., Müller-Eberhard H.J., Aiken B.S. Depletion of plasma complement in vivo by a protein of cobra venom: its effects on various immunologic reactions. J. Immunol. 105:1970;55-69.
2. Dalemans W., Perraud F., Le-Meur M., Gerlinger P., Courtney M., Pavirani A. Heterologous protein expression by transimmortalized differentiated liver cell lines derived from transgenic mice. Biologicals. 18:1990;193-198.
3. Emmerling M.R., Watson M.D., Raby C.A., Spiegel K. The role of complement in Alzheimer's disease pathology. Biochim. Biophys. Acta. 1502:2000;158-171.
4. Finnie J.C., Stewart R.B., Aston W.P. A comparison of cobra venom factor-induced depletion of serum C3 in eight different strains of mice. Dev. Comp. Immunol. 5:1981;697-701.
5. Fischer M.B., Ma M., Hsu N.C., Carroll M.C. Local synthesis of C3 within the splenic lymphoid compartment can reconstitute the impaired immune response in C3-deficient mice. J. Immunol. 160:1998;2619-2625.
6. Fodor W.L., Rollins S.A., Guilmette E.R., Setter E., Squinto S.P. A novel bifunctional chimeric complement inhibitor that regulates C3 convertase and formation of the membrane attack complex. J. Immunol. 155:1995;4135-4138.
7. Fritzinger D.C., Bredehorst R., Vogel C.W. Molecular cloning and derived primary structure of cobra venom factor. Proc. Natl. Acad. Sci. U.S.A. 91:1994;12775-12779.
8. Goodfellow R.M., Williams A.S., Levin J.L., Williams B.D., Morgan B.P. Soluble complement receptor one (sCR1) inhibits the development and progression of rat collagen-induced arthritis. Clin. Exp. Immunol. 119:2000;210-216.
9. Hogan, B., Beddingtin, R., Costantini, F., Lacy, E., 1994. Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
10. Kinoshita T. Biology of complement: the overture. Immunol. Today. 12:1991;291-295.
11. Kobayashi T., Tanigushi S., Neethling F.A., Rose A.G., Hancock W.W., Ye Y., Niekrasz M., Kosanke S., Wright L.J., white D.J., Cooper D.K. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation. 64:1997;1255-1261.
12. Kock M.A., 1996. Expression and Characterization of Recombinant Cobra Venom Factor. Wissenschaft und Technik Verlag, Berlin, Germany.
13. Kock M.A., Ziegelmüller P., Bredehorst R., Vogel C.W. Recombinant expression of active cobra venom factor (CVF). Mol. Immunol. 33(Suppl. 1):1996;15.
14. Kondoh N., Noda M., Fisher R.J., Schweinfest C.W., Papas T.S., Kondoh A., Samuel K.P., Oikawa T. The S29 ribosomal protein increases tumor suppressor activity of K rev-1 gene on v-K ras-transformed NIH3T3 cells. Biochim. Biophys. Acta. 1313:1996;41-46.
15. Kroshus T.J., Rollins S.C., Dalmasso A.P., Elliott E.A., Matis L.A., Squinto S.P., III R.M.B. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation. Transplantation. 60:1995;1194-1202.
16. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
17. Müller-Eberhard H.J. Molecular organization and function of the complement system. Ann. Rev. Biochem. 57:1988;321-347.
18. Oberholzer J., Yu D., Triponez F., Cretin N., Andereggen E., Mentha G., White D., Buehler L., Morel P., Lou J. Decomplementation with cobra venom factor prolongs survival of xenografted islets in a rat to mouse model. Immunology. 97:1999;173-180.
19. Platt J.L., Saadi S. The role of complement in transplantation. Mol. Immunol. 36:1999;965-971.
20. Sahu A., Lambris J.D. Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics. Immunopharmacology. 49:2000;133-148.
21. Sambrook, J., Fritsch, E.F., Maniatis, T., 1992. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
22. 1-antitrypsin gene in transgenic mice. Nucleic Acids Res. 15:1987;1459-1475.
23. Thomas T.C., Rollins S.A., Rother R.P., Giannoni M.A., Hartman S.L., Elliott E.A., Nye S.H., Matis L.A., Squinto S.P., Evans M.J. Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv. Mol. Immunol. 33:1996;1389-1401.
24. Van den Berg C.W., Aerts P.C., Van Dijk H. Functional assay of C5-activating and non-activating cobra venom factor preparations in the mouse system. J. Immunol. Methods. 133:1990;199-206.
25. Van den Berg C.W., Van Dijk H., Capel P.J.A. Rapid isolation and characterization of native mouse complement components C3 and C5. J. Immunol. Methods. 122:1989;73-78.
26. Vogel, C.W., 1991. Cobra venom factor: The complement-activating protein of cobra venom. In: Tu, A.T. (Ed.), Handbook of Natural Toxins, Reptile Venoms and Toxins. Marcel Dekker, New York, pp. 147-188.
27. Vogel, C.W., Bredehorst, R., Fritzinger, D.C., Grunwald, T., Ziegelmüller, P., Kock, M.A., 1996. Structure and function of cobra venom factor, the complement-activating protein in cobra venom. In: Singh, B.R., Tu, A.T. (Eds.), Natural Toxins, Vol. II. Plenum Press, New York, pp. 97-114.
28. Vogel C.W., Müller-Eberhard H.J. Cobra venom factor: improved method for purification and biochemical characterization. J. Immunol. Methods. 73:1984;203-220.
29. Wang Y., Kristan J., Hao L., Lenkoski C.S., Shen Y., Matis L.A. A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis. J. Immunol. 164:2000;4340-4347.
30. Wang Y., Rollins S.A., Madri J.A., Matis L.A. Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. Proc. Natl. Acad. Sci. U.S.A. 92:1995;8955-8959.
31. Weisman, H.F., Bartow, T., Leppo, M.K., Marsh Jr., H.C., Carson, G.R., Concino, M.F., Boyle, M.P., Roux, K.H., Weisfeldt M.L., Fearon D.T., 1990. Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249, 146-151.
32. Wessels M.R., Butko P., Ma M., Warren H.B., Lage A.L., Carroll M.C. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. U.S.A. 92:1995;11490-11494.
33. Zhou W., Farrar C.A., Abe K., Pratt J.R., Marsh J.E., Wang Y., Stahl G.L., Sacks S.H. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J. Clin. Invest. 105:2000;1363-1371.